Zinc status is not adversely affected by folic acid supplementation and zinc intake does not impair folate utilization in human subjects.
Changes in zinc status in response to folic acid supplementation and the effect of zinc intake on folate utilization were evaluated in 12 men (20-34 y old) consuming a diet containing 3.5 or 14.5 mg zinc/d for two 25-d intervals. Deuterium-labeled folic acid (800 micrograms/d) or a placebo was administered orally during each phase. No differences in plasma zinc, erythrocyte zinc, urinary zinc, erythrocyte metallothionein or serum alkaline phosphatase, due to supplemental folic acid, were detected at either level of zinc intake. Differences in the response to folic acid supplementation, due to the level of zinc intake, were not detected for serum, erythrocyte or urinary (labeled and unlabeled) folate. Within the constraints of this short-term folic acid supplementation study, adverse effects on zinc status were not observed and our data suggest that folic acid utilization was not influenced by level of zinc intake.
Kauwell
G P
GP
Food Science and Human Nutrition Department, University of Florida, Gainesville 32611.
Bailey
L B
LB
Gregory
J F
JF
Bowling
D W
DW
Cousins
R J
RJ
D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D018592:Cross-Over Studies; D004347:Drug Interactions; D004912:Erythrocytes / Q000378:metabolism; D005293:Ferritins / Q000097:blood; D005492:Folic Acid / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005527:Food, Fortified; D006801:Humans; D008297:Male; D008668:Metallothionein / Q000097:blood; D016037:Single-Blind Method; D015032:Zinc / Q000008:administration & dosage* / Q000097:blood / Q000652:urine
D005293:Ferritins; D008668:Metallothionein; D005492:Folic Acid; D000469:Alkaline Phosphatase; D015032:Zinc